Literature DB >> 26116500

Dissecting CD8+ NKT Cell Responses to Listeria Infection Reveals a Component of Innate Resistance.

Sergey S Seregin1, Grace Y Chen2, Yasmina Laouar3.   

Abstract

A small pool of NK1.1(+) CD8(+) T cells is harbored among the conventional CD8(+) T cell compartment. Conclusions drawn from the analysis of immune responses mediated by cytotoxic CD8(+) T cells are often based on the total population, which includes these contaminating NK1.1(+) CD8(+) T cells. An unresolved question is whether NK1.1(+) CD8(+) cells are conventional T cells that acquire NK1.1 expression upon activation or delineation into memory phenotype or whether they are a distinct cell population that induces immune responses in a different manner than conventional T cells. To address this question, we used the Listeria monocytogenes model of infection and followed CD8(+) NK1.1(+) T cells and NK1.1(-) CD8(+) T cells during each phase of the immune response: innate, effector, and memory. Our central finding is that CD8(+) NK1.1(+) cells and conventional NK1.1(-) CD8(+) T cells both contribute to the adaptive immune response to Listeria, but only CD8(+) NK1.1(+) cells were equipped with the ability to provide a rapid innate immune response, as demonstrated by early and Ag-independent IFN-γ production, granzyme B expression, and degranulation. More importantly, purified conventional CD8(+) T cells alone, in the absence of any contaminating CD8(+) NK1.1(+) cells, were not sufficient to provide early protection to lethally infected mice. These results highlight the role of CD8(+) NK1.1(+) T cells in mounting early innate responses that are important for host defense and support the therapeutic potential of this subset to improve the effectiveness of protective immunity.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26116500      PMCID: PMC4506885          DOI: 10.4049/jimmunol.1500084

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.

Authors:  M K Slifka; R R Pagarigan; J L Whitton
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Three day neonatal thymectomy selectively depletes NK1.1+ T cells.

Authors:  K Hammond; W Cain; I van Driel; D Godfrey
Journal:  Int Immunol       Date:  1998-10       Impact factor: 4.823

3.  Mouse NK1.1+ cytotoxic T cells can be generated by IL-2 exposure from lymphocytes which express an intermediate level of T cell receptor.

Authors:  Y Ikarashi; H Maruoka; K Shinohara; T Sugimura; M Terada; H Wakasugi
Journal:  Immunol Lett       Date:  1998-04       Impact factor: 3.685

4.  Coordinate regulation of complex T cell populations responding to bacterial infection.

Authors:  D H Busch; I M Pilip; S Vijh; E G Pamer
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

5.  T lymphocyte dynamics during Listeria monocytogenes infection.

Authors:  D H Busch; E G Pamer
Journal:  Immunol Lett       Date:  1999-01       Impact factor: 3.685

6.  Early IFN-gamma production and innate immunity during Listeria monocytogenes infection in the absence of NK cells.

Authors:  A Andersson; W J Dai; J P Di Santo; F Brombacher
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

Review 7.  Immune responses to Listeria monocytogenes.

Authors:  Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

8.  Analysis of the role of natural killer cells in Listeria monocytogenes infection: relation between natural killer cells and T-cell receptor gamma delta T cells in the host defence mechanism at the early stage of infection.

Authors:  H Takada; G Matsuzaki; K Hiromatsu; K Nomoto
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

9.  Role of NK1.1+ cells in experimental listeriosis. NK1+ cells are early IFN-gamma producers but impair resistance to Listeria monocytogenes infection.

Authors:  H C Teixeira; S H Kaufmann
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

10.  Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen.

Authors:  Rance E Berg; Emily Crossley; Sean Murray; James Forman
Journal:  J Exp Med       Date:  2003-11-17       Impact factor: 14.307

View more
  6 in total

1.  High Frequency of Gamma Interferon-Producing PLZFloRORγtlo Invariant Natural Killer 1 Cells Infiltrating Herpes Simplex Virus 1-Infected Corneas Is Associated with Asymptomatic Ocular Herpesvirus Infection.

Authors:  Nisha R Dhanushkodi; Ruchi Srivastava; Swayam Prakash; Soumyabrata Roy; Pierre-Gregoire A Coulon; Hawa Vahed; Angela M Nguyen; Stephanie Salazar; Lan Nguyen; Cassandra Amezquita; Caitlin Ye; Vivianna Nguyen; Lbachir BenMohamed
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

2.  Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.

Authors:  Weici Zhang; Ren Zhang; Jun Zhang; Ying Sun; Patrick Sc Leung; Guo-Xiang Yang; Zongwen Shuai; William M Ridgway; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

3.  Three paralogous clusters of the miR-17~92 family of microRNAs restrain IL-12-mediated immune defense.

Authors:  Xiang Zhang; Sinead M Smith; Xi Wang; Baohong Zhao; Li Wu; Xiaoyu Hu
Journal:  Cell Mol Immunol       Date:  2020-02-03       Impact factor: 22.096

4.  Functional Characterization of Ly49+CD8 T-Cells in Both Normal Condition and During Anti-Viral Response.

Authors:  Dmytro Shytikov; Deepak Rohila; Dan Li; Pengfei Wang; Mei Jiang; Mingxu Zhang; Qin Xu; Linrong Lu
Journal:  Front Immunol       Date:  2021-01-07       Impact factor: 7.561

Review 5.  CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential.

Authors:  Vanaja Konduri; Damilola Oyewole-Said; Jonathan Vazquez-Perez; Scott A Weldon; Matthew M Halpert; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

6.  A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer.

Authors:  Wanjun Yu; Fei Ye; Xiao Yuan; Yali Ma; Chaoming Mao; Xiaoqin Li; Jian Li; Chunhua Dai; Fenhong Qian; Junrong Li; Xiujuan Fan; Yuepeng Zhou; Deqiang Wang; Zhenhong Guo; Huazhang An; Minghui Zhang; Deyu Chen; Sheng Xia
Journal:  BMC Cancer       Date:  2021-07-31       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.